Entera Bio
ENTX
5 hedge funds and large institutions have $2.36M invested in Entera Bio in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.25% less ownership
Funds ownership: 10.7% → 10.45% (-0.25%)
31% less capital invested
Capital invested by funds: $3.42M → $2.36M (-$1.06M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$139K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$33.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM
Wildcat Capital Management
New York
|
-$269K |
| 2 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$37.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.86K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Knoll Capital Management
Miami,
Florida
| $2.16M | – | – | – |
|
|
WS
2
Wedbush Securities
Los Angeles,
California
| $151K | +$139K | +91,608 | +305% |
|
|
3
Citadel Advisors
Miami,
Florida
| $28K | +$33.4K | +22,020 | New |
|
|
PF
4
Phoenix Financial
Givatayim,
Israel
| $15K | -$37.9K | -25,000 | -67% |
|
|
5
UBS Group
Zurich,
Switzerland
| $10K | -$3.86K | -2,544 | -25% |
|
|
WCM
6
Wildcat Capital Management
New York
| – | -$269K | -130,926 | Closed |
|
ENTX Hedge Fund Activity: Q3 2020 in Review
5 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q3 2020, worth a combined $2.36M — down 31% from $3.42M a quarter earlier.
Fund positioning in ENTX was balanced in Q3 2020: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Wedbush Securities, adding an estimated $139K. The largest seller was Wildcat Capital Management, exiting entirely with an estimated $269K sold.
- 5 institutional investors held Entera Bio (ENTX) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $2.36M of Entera Bio stock for Q3 2020, down 31% quarter-over-quarter.
- 1 fund opened new Entera Bio positions in Q3 2020 and 1 closed out, a net change of 0 holders.
- The largest Entera Bio buyer in Q3 2020 was Wedbush Securities, an estimated $139K added.
- The largest Entera Bio seller in Q3 2020 was Wildcat Capital Management, an estimated $269K sold.
Based on aggregated 13F filings for Q3 2020.